Location History:
- Enghien-les-Bains, FR (2008)
- Paris, FR (2010)
Company Filing History:
Years Active: 2008-2010
Title: Maria-Carmen Renones: Innovator in Therapeutic Compounds
Introduction
Maria-Carmen Renones is a prominent inventor based in Paris, France. She has made significant contributions to the field of therapeutic compounds, holding 2 patents that focus on innovative treatments for various medical conditions. Her work is characterized by a commitment to advancing healthcare through scientific research and development.
Latest Patents
Renones' latest patents include groundbreaking compounds that have therapeutic applications. One patent involves derivatives of pyrrolizine, indolizine, and quinolizine, which are designed for therapeutic use. This patent details a compound of formula (I) and includes processes for preparing these compounds, as well as their potential therapeutic applications. Another patent focuses on derivatives of N-[heteroaryl(piperidine-2-yl) methyl]benzamide, which are useful in treating a range of behavioral disorders associated with dementia, psychoses, anxiety, depression, and various pain conditions. These compounds are also indicated for the treatment of Parkinson's disease and epilepsy, showcasing their versatility in addressing complex health issues.
Career Highlights
Maria-Carmen Renones is affiliated with Sanofi-Aventis, a leading global healthcare company. Her role at the company allows her to collaborate with other experts in the field and contribute to the development of innovative therapeutic solutions.
Collaborations
Renones has worked alongside notable colleagues such as Gihad Dargazanli and Genevieve Estenne-Bouhtou. These collaborations have further enriched her research and development efforts, leading to advancements in therapeutic applications.
Conclusion
Maria-Carmen Renones exemplifies the spirit of innovation in the pharmaceutical industry. Her patents and collaborative efforts reflect her dedication to improving patient outcomes through effective therapeutic solutions.